WebIohexol. Basics. Name. Iohexol. Special Alerts. Iodine-Containing Contrast Safety Alert March 2024. The FDA has approved a new warning to the prescribing information of iodinated contrast media agents and is reco... This item requires a subscription. WebIohexol Injection is a sterile solution of Iohexol in Water for Injection. It contains NLT 95.0% and NMT 105.0% of the labeled amount of iohexol (C 19 H 26 I 3 N 3 O 9) as organically …
OMNIPAQUE™ (iohexol) Injection 300 350 - DailyMed
WebPRESCRIBING INFORMATION OMNIPAQUE™ (iohexol) Please refer to full national Summary of Product Characteristics (SPC) before ... PRESENTATION Aqueous solution for injection containing iohexol, a non-ionic, monomeric, triiodinated X-ray contrast medium, and available in strengths containing either 140 mg, 240 mg, 300 mg or 350 mg iodine ... WebOMNIPAQUE (iohexol) injection, for intrathecal, intravascular, oral , rectal, intraarticular, or body cavity use. OMNIPAQUE (iohexol) oral solution . Initial U.S. Approval: 1985 . … greenish brownish bug
OMNIPAQUE™ (iohexol) Injection 140 180 240 300 350 140 350 NOT FOR ...
WebIohexol SELECT Generic Medicine Info Full Generic Medicine Info Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Pregnancy Category (US … Web6 jul. 2007 · Iohexol. DrugBank Accession Number. DB01362. Background. Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Type. WebSee full Prescribing Information for complete Boxed Warning. Omnipaque Injections 140 and 350 are contraindicated for intrathecal use. Inadvertent intrathecal administration may cause death, convulsions/seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac greenish brown mucus means